Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.1157
Abstract: Importance In patients treated with ω-3 fatty acids, it remains uncertain whether achieved levels of eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) are associated with cardiovascular outcomes. Objective To determine the association between plasma levels… read more here.
Keywords: acid; trial; cardiovascular outcomes; corn oil ... See more keywords
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2023.4602
Abstract: This secondary analysis evaluates antihyperglycemic treatments, hypoglycemic episodes, and risk for cardiovascular events and mortality in 2 randomized clinical trials involving adults with type 2 diabetes. read more here.
Keywords: carolina trials; carmelina carolina; outcomes carmelina; trials linagliptin ... See more keywords
Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0055
Abstract: Key Points Question How does an intensive lifestyle intervention affect the association between variability in adiposity indices and cardiovascular outcomes and deaths among adults with type 2 diabetes? Findings In this cohort study of 3604… read more here.
Keywords: variability; type diabetes; intervention; weight loss ... See more keywords
Incidence and Risk of Cardiovascular Outcomes in Patients With Anorexia Nervosa
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.51094
Abstract: Key Points Question Do patients with anorexia nervosa (AN) have an increased risk of cardiovascular conditions? Findings In this cohort study including 2081 patients with AN and 20 810 matched controls, the AN group had an… read more here.
Keywords: patients anorexia; risk; risk cardiovascular; cardiovascular outcomes ... See more keywords
Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA pediatrics"
DOI: 10.1001/jamapediatrics.2024.1543
Abstract: Importance Hypertension affects 6% of all children, and its prevalence is increasing. Childhood hypertension tracks into adulthood and is associated with subclinical cardiovascular disease; however, there is a lack of evidence linking childhood hypertension to… read more here.
Keywords: disease; long term; mace; cardiovascular outcomes ... See more keywords
Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
Sign Up to like & getrecommendations! Published in 2024 at "Clinical Cardiology"
DOI: 10.1002/clc.24248
Abstract: Sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have been demonstrated to decrease cardiovascular adverse events. However, there is little real‐world clinical evidence regarding a direct comparison between dapagliflozin and empagliflozin in patients with diabetes mellitus (DM). read more here.
Keywords: patients diabetes; diabetes mellitus; outcomes dapagliflozin; cardiovascular outcomes ... See more keywords
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment
Sign Up to like & getrecommendations! Published in 2018 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12331
Abstract: Left atrium (LA) dilation is associated with adverse cardiovascular (CV) outcomes. Blood stasis, thrombus formation and atrial fibrillation may occur, especially in heart failure (HF) patients. It is not known whether preventive antithrombotic treatment may… read more here.
Keywords: antithrombotic treatment; heart; cardiovascular outcomes; heart failure ... See more keywords
Do adrenergic alpha‐antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14012
Abstract: Due to concerns regarding neurohormonal activation and fluid retention, adrenergic alpha‐1 receptor antagonists (A1Bs) are generally avoided in the setting of heart disease, namely, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF). However, this… read more here.
Keywords: meta analysis; adrenergic alpha; meta; heart ... See more keywords
Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14213
Abstract: Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively evaluated. We aimed to perform a meta‐analysis of digitalized individual patient outcomes to display and compare absolute… read more here.
Keywords: novel antidiabetic; antidiabetic drugs; numbers needed; drugs cardiovascular ... See more keywords
Long‐term cardiovascular outcomes and mortality with enzyme replacement therapy in patients with mucopolysaccharidosis type II
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Inherited Metabolic Disease"
DOI: 10.1002/jimd.12779
Abstract: Mucopolysaccharidosis type II (MPS II) is a rare multisystemic lysosomal disorder in which cardiac issues can lead to serious dysfunction and an increased risk of fatal cardiac failure. However, studies on major adverse cardiac event… read more here.
Keywords: mucopolysaccharidosis type; enzyme replacement; risk; replacement therapy ... See more keywords
Trajectories of Lipid Profile Changes and Cardiovascular Outcomes in Elderly Asian Patients With Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.70151
Abstract: The relationship between baseline total cholesterol, low‐density lipoprotein (LDL), high‐density lipoprotein (HDL) and cardiovascular outcomes is well established, but their trajectories over time in elderly Asian patients with atrial fibrillation (AF) remain unexplored. read more here.
Keywords: asian patients; elderly asian; cardiovascular outcomes; patients atrial ... See more keywords